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Abstract 
In a patient with systemic lupus erythematosus (SLE), we considered the diagnosis of autoimmune hepatitis (AIH) in 
view of raised serum aminotransferases, hypergammaglobulinaemia, antinuclear antibodies (titre 1:10240), seronegativity of 
markers for viral hepatitis and absence of recent hepatotoxic drug usage. The diagnosis of AIH was supported by using the 
scoring system, recently developed by the International Autoimmune Hepatitis Group and the excellent response to treatment 
with prednisone. Liver histology, however, showed no characteristic features of AIH. The relevance of liver histology and 
scoring for AIH in SLE with hepatic involvement is discussed. 
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1. Introduction 
Systemic lupus erythematosus (SLE) is an au- 
toimmune disorder affecting multiple organs. In SLE 
patients, increased serum values, of liver enzymes are 
common [1-4]. High incidences of hepatic conges- 
tion (76%), fatty liver (73%), arteriitis (21%) and 
cholestasis (17%) have been reported in 53 autopsied 
patients with SLE, in whom drug-induced effects 
were not excluded [5]. Autoimmune hepatitis (AIH) 
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has been considered to occur infrequently in SLE 
[5,6]. The International Autoimmune Hepatitis Group 
has recently presented a scoring system for the diag- 
nosis of AIH [7]. Based on these defined diagnostic 
criteria, we considered the diagnosis of AIH in a 
patient with SLE, and discuss the relevance of the 
scoring system for AIH and liver histology in SLE 
with hepatic involvement. 
2. Case report 
A 20-year-old black female presented with a 3- 
week history of fatigue, malaise, myalgias, episodic 
fever and weight loss (6 kg). Three months before 
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admission she started to complain of alopecia and 
arthralgias in both hips and knees. From a year 
before referral a positive Raynaud's phenomenon 
was noticed, and pigmented macules successively 
arose on the palms, soles and face. Three years 
before she had been adequately treated for pul- 
monary tuberculosis. Since then she had not taken 
any medication. Especially there was no history of 
recent hepatotoxic drug usage or parenteral exposure 
to blood products. There was no family history of 
SLE or liver disease. 
On physical examination her temperature was 
36.6°C increasing to 40.0°C. Pigmented macules and 
erythematous lesions with central atrophy and locally 
firmly adherent keratosis were prominent on areas of 
the skin exposed to cold (hands, feet and nose). 
Retinal vasculitis with cotton wools (cytoid bodies) 
were observed during fundoscopy. There was no 
suspicion of CMV retinitis. Further examination re- 
vealed no joint swelling, hepatomegaly or stigmata 
of chronic liver disease. 
Laboratory data are shown in Table 1, revealing 
an autoimmune haemolytic anaemia, leucopenia, in- 
creased levels of liver enzymes, hypergammaglobuli- 
naemia and hypocomplementaemia, all convalescent 
during treatment. Antinuclear antibodies (ANA) were 
prominently positive (titre = 1:10 240) with the pres- 
ence of anti-Sm, anti-SS-A and anti-RNP antibodies. 
Anti-mitochondrial, smooth muscle, skin, granulo- 
cyte and thrombocyte antibodies were negative. 
Serum values of urea, creatinine, electrolytes, glu- 
cose and TSH were within normal imits. Urinalysis 
revealed no abnormalities. Cultures from blood and 
skin lesions were negative. There was no evidence of 
mycobacterium in sputum, gastric acid secrete or 
urine. Serological tests on hepatotropic viruses were 
negative, except for IgG and IgM anti-CMV, show- 
ing moderately elevated titres unchanged as com- 
pared with those found 6 months before. CMV IEA 
(= immediate arly antigen) in the buffy coat and 
viral culture on CMV in urine were negative. 
The chest X-ray showed remnants of the pul- 
monary tuberculosis. Ultrasound echography of the 
abdomen revealed no abnormalities, but histological 
findings in a liver biopsy specimen showed a mild 
hepatitis with lobular activity and degeneration of 
Table 1 
Laboratory data 







SGOT( = ASAT) 
SGPT( = ALAT) 
LDH 
Haptoglobin 













74 12 < 10 mm/h 
6.5 7.9 7.3-9.3 mmol/l 
2.3 5.9 4.0-10.0 x 109/1 
16 8 4-14/zmol/l 
106 50 25-75 U/1 
138 29 5-35 U/I 
293 21 5-30 U/I 
84 21 5-30 U/1 
1 463 274 160-320 U/I 
< 0.08 0.57 0.50-2.70 g/I 
positive 
257 34 15-110 U/I 
5.3 2.8 1.0-3.0 U/I 
0.37 0.79 0.80-1.60 g/ l  
< 0.08 0.08 0.15-0.40 g/l  
71 239 101-300 U/ml 
24.8 19.7 8.0-18.0 g/I 
4.0 3.7 0.9-4.5 g/l  
1.2 1.0 0.6-2.8 g/ l  
81 0-31 U/1 
8 0-12 U/1 
1:10240 
positive 
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Fig. I. Liver biopsy specimen shows only a limited portal infiltrate (open arrow) and isolated egeneration f hepatocytes ( olid arrow) in a 
patient with SLE. 
hepatocytes, without piecemeal necrosis or evident 
rosetting of liver cells (Fig. 1). Copper stains were 
negative. Frozen sections of a biopsy specimen from 
macroscopically normal skin showed depositions of 
IgG and complement along the basal membrane of 
the epidermis and that of skin appendages. ANA 
Table 2 
Diagnosis of autoimmune hepatitis in our patient according to scoring system a
Required parameters 
Female 
Ratio of serum alkaline phosphatase to aminotransferase ctivities (in IU/I) < 3.0 
Total serum globulin or gammaglobulin or lgG: times upper limit = 1.0-1.5 
Autoantibodies (titres ANA/SMA/LKM-1) ;  adults > 1:80; children > 1:20 
Seronegative for markers hepatitis A, B and C 
No history of recent hepatotoxic drug usage or parenteral exposure to blood products 
Alcohol average consumption < 25 g/day 
Other autoimmune disease in patient 
Additional parameters 
Complete response to therapy 














a Scoring system for autoimmune hepatitis recently defined by the International Autoimmune Hepatitis Group (7). 
b Interpretation of scores before and after treatment: 
BeJbre After Diagnosis 
> 15 > 17 definite autoimmune hepatitis 
I 0-15 12-17 probable autoimmune h patitis 
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were also present. The clinical picture combined 
with the haematological nd immunological findings 
are consistent with a diagnosis of SLE according to 
the revised ACR criteria [8]. In SLE, raised serum 
aminotransferases ( pecially SGOT) may also fit in 
with the diagnosis of (dermato)myositis [9]. Indeed, 
in this patient a mild myositis was present, but the 
concurrent increase of SGPT, 7-glutamyl transpepti- 
dase and alkaline phosphatase is clearly indicative 
for hepatitis. 
According to the scoring system defined by the 
International Autoimmune Hepatitis Group [7] the 
diagnosis of AIH was probable in our patient (Table 
2). She was treated with prednisone 30 mg and 
hydroxychloroquine 200 mg, both once daily. The 
clinical picture improved excellently, and the ESR, 
leucocyte counts, serum levels of liver enzymes, 
haptoglobin and complement ormalized completely 
within 4 weeks. Review of the liver biopsy by an 
independent hepatologist and pathologist cast doubt 
on the diagnosis of AIH in view of the absence of 
characteristic abnormalities such as piecemeal necro- 
sis and rosetting of liver cells. 
lar and occasionally (peri)portal with a paucity of 
lymphoid infiltrates [6,10,11 ]. Leucopenia, hemolytic 
anaemia nd malar rash are clearly in favour of SLE 
[6]. Coexistence of SLE with primary biliary cirrho- 
sis has been described [12]. Histological findings and 
the absence of antimitochondrial antibodies did not 
support his diagnosis in our patient. 
We report a probable AIH according to the scor- 
ing system for this diagnosis (7) in a 20-year-old 
woman with active SLE [8]. The absence of piece- 
meal necrosis and rosetting of liver cells in the 
present case, however, points to SLE-associated hep- 
atitis rather than to AIH. This case emphasizes that 
increased serum levels of liver enzymes in active 
SLE ask for liver histology to differentiate between 
SLE-associated hepatitis and AIH. Further refine- 
ment of the scoring system for AIH appears desir- 
able. We think that the actual scoring system for 
AIH should be used with caution if histopathological 
findings are not available in patients with liver en- 
zyme abnormalities in the context of SLE and other 
autoimmune diseases; the minimal histological re- 
quirements for the diagnosis of AIH should be pre- 
sent. 
3. Discussion 
Hepatic involvement in SLE is common. Varying 
incidences of hepatic ongestion, fatty liver, arteriitis 
and cholestasis are reported, but the relation to hepa- 
totoxic drug usage and the presence of viral hepatitis 
is unknown [3-7]. From a prospective study it be- 
comes clear that in about one third of patients with 
SLE and raised serum transaminases, usually mild 
(often Iobular, as in this patient) hepatitis is not 
associated with drugs or alcohol as a cause, but 
reflects disease activity of SLE [10]. AIH and SLE- 
associated hepatitis have been defined as two differ- 
ent entities [6], although both have features of an 
autoimmune disorder, such as polyarthralgia, hyper- 
gammaglobulinaemia andpresence of ANA, anti-Sm, 
anti-RNP and anti-cardiolipin antibodies [6,10,11 ]. 
This may lead to diagnostic onfusion. Several histo- 
logical and clinical features discriminate AIH from 
SLE [6,10,11]. Periportal piecemeal necrosis variably 
associated with lobular activity, rosetting of liver 
cells and dense lymphoid infiltrates are prominent in 
AIH, while in SLE the inflammation is usually lobu- 
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